secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0000950170-23-039068
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight Q2 revenue $20.8M (+83% YoY); raises FY2023 guidance; pays off $40M debt
--------------------------------------------------------------------------------

- Q2 revenue $20.8M (+83% YoY); net loss $(13.8)M vs $(16.7)M last year.
- Raised FY2023 revenue guidance to $81-86M (prior $79-84M); gross margin 58-60%.
- LAL procedure volumes 12,622 (+134% YoY); LDD installed base 523 (+78% YoY).
- Paid off $40M debt in Q2 and early Q3, eliminating ~$5.6M annual interest expense.
- Raised ~$31.3M net from ATM in Q2 and early Q3 to fund debt repayment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000095017023039068/0000950170-23-039068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000095017023039068/rxst-20230807.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-039068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer